A panel headed by Cabinet Secretary Rajiv Gauba will examine allocating more funds towards vaccine production to boost manufacturing production-linked incentive (PLI) scheme.
The department of pharmaceuticals has urged the top government panel to provide additional funds of around Rs 3,000 crore under the scheme for pharmaceutical drugs. The scheme is aimed at further boosting domestic manufacturing of medicines, in-vitro diagnostics (IVD), and their raw materials in India.
The additional amount is being asked to support the domestic production of raw materials required for vaccine production, people aware of the matter told Business Standard. The financial outlay for the scheme is currently

)